ID   PIGG_HUMAN              Reviewed;         983 AA.
AC   Q5H8A4; B4DKC7; Q2TAK5; Q6UX31; Q7L5Y4; Q8N866; Q8NCC9; Q96SY9;
AC   Q9BVT7; Q9NXG5;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   10-MAY-2017, entry version 105.
DE   RecName: Full=GPI ethanolamine phosphate transferase 2;
DE            EC=2.-.-.-;
DE   AltName: Full=GPI7 homolog;
DE            Short=hGPI7;
DE   AltName: Full=Phosphatidylinositol-glycan biosynthesis class G protein;
DE            Short=PIG-G;
GN   Name=PIGG; Synonyms=GPI7; ORFNames=UNQ1930/PRO4405;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH PIGF.
RX   PubMed=15632136; DOI=10.1074/jbc.M413755200;
RA   Shishioh N., Hong Y., Ohishi K., Ashida H., Maeda Y., Kinoshita T.;
RT   "GPI7 is the second partner of PIG-F and involved in modification of
RT   glycosylphosphatidylinositol.";
RL   J. Biol. Chem. 280:9728-9734(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 367-983 (ISOFORM 1), AND VARIANT
RP   ILE-699.
RC   TISSUE=Cervix, Colon mucosa, Teratocarcinoma, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS
RP   HIS-458; ARG-610 AND ILE-699.
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANT MRT53 CYS-669, INVOLVEMENT IN MRT53, AND CHARACTERIZATION OF
RP   VARIANT MRT53 CYS-669.
RX   PubMed=26996948; DOI=10.1016/j.ajhg.2016.02.007;
RA   Makrythanasis P., Kato M., Zaki M.S., Saitsu H., Nakamura K.,
RA   Santoni F.A., Miyatake S., Nakashima M., Issa M.Y., Guipponi M.,
RA   Letourneau A., Logan C.V., Roberts N., Parry D.A., Johnson C.A.,
RA   Matsumoto N., Hamamy H., Sheridan E., Kinoshita T., Antonarakis S.E.,
RA   Murakami Y.;
RT   "Pathogenic variants in PIGG cause intellectual disability with
RT   seizures and hypotonia.";
RL   Am. J. Hum. Genet. 98:615-626(2016).
CC   -!- FUNCTION: Ethanolamine phosphate transferase involved in
CC       glycosylphosphatidylinositol-anchor biosynthesis. Transfers
CC       ethanolamine phosphate to the GPI second mannose.
CC       {ECO:0000269|PubMed:15632136}.
CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-
CC       anchor biosynthesis.
CC   -!- SUBUNIT: Forms a complex with PIGF. PIGF is required to stabilize
CC       it. Competes with PIGO for the binding of PIGF.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15632136}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15632136}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q5H8A4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5H8A4-2; Sequence=VSP_019832;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q5H8A4-3; Sequence=VSP_019828;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q5H8A4-4; Sequence=VSP_019831, VSP_019833;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5;
CC         IsoId=Q5H8A4-5; Sequence=VSP_019827, VSP_019829, VSP_019830;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q5H8A4-6; Sequence=VSP_054387, VSP_054388, VSP_019833;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Mental retardation, autosomal recessive 53 (MRT53)
CC       [MIM:616917]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. Most MRT53 patients
CC       manifest severely delayed psychomotor development, hypotonia, and
CC       early-onset seizures. Additional features, such as cerebellar
CC       hypoplasia and ataxia have been observed in some patients.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry. Cells from patients carrying PIGG
CC       disease-causing mutations show abnormal accumulation of the GPI
CC       precursors H7 and H7' and absence of mature GPI precursor H8,
CC       consistent with a loss of function. However, GPI-anchored
CC       proteins, including CD59, CD55, CD24 and CD16, are normally
CC       expressed at the cell surface of lymphocytes and granulocytes and
CC       CD59 exhibits sensitivity to bacterial phosphatidylinositol-
CC       specific phospholipase C, suggesting a normal structure. The role
CC       of PIGG in MRT53 etiology is not clear.
CC       {ECO:0000269|PubMed:26996948}.
CC   -!- SIMILARITY: Belongs to the PIGG/PIGN/PIGO family. PIGG subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ88902.1; Type=Erroneous termination; Positions=311; Note=Translated as Gln.; Evidence={ECO:0000305};
CC       Sequence=BAA91046.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB55130.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB162713; BAD89023.1; -; mRNA.
DR   EMBL; AY358538; AAQ88902.1; ALT_SEQ; mRNA.
DR   EMBL; AK074815; BAC11227.1; -; mRNA.
DR   EMBL; AK000272; BAA91046.1; ALT_INIT; mRNA.
DR   EMBL; AK027465; BAB55130.1; ALT_INIT; mRNA.
DR   EMBL; AK097244; BAC04984.1; -; mRNA.
DR   EMBL; AK296507; BAG59139.1; -; mRNA.
DR   EMBL; AC092574; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000937; AAH00937.2; -; mRNA.
DR   EMBL; BC001249; AAH01249.2; -; mRNA.
DR   EMBL; BC110878; AAI10879.1; -; mRNA.
DR   CCDS; CCDS3336.1; -. [Q5H8A4-2]
DR   CCDS; CCDS46992.1; -. [Q5H8A4-1]
DR   CCDS; CCDS75080.1; -. [Q5H8A4-3]
DR   CCDS; CCDS75083.1; -. [Q5H8A4-5]
DR   RefSeq; NP_001120650.1; NM_001127178.2. [Q5H8A4-1]
DR   RefSeq; NP_001275980.1; NM_001289051.1.
DR   RefSeq; NP_001275981.1; NM_001289052.1. [Q5H8A4-3]
DR   RefSeq; NP_001275984.1; NM_001289055.1. [Q5H8A4-6]
DR   RefSeq; NP_001275986.1; NM_001289057.1. [Q5H8A4-5]
DR   RefSeq; NP_060203.3; NM_017733.4. [Q5H8A4-2]
DR   UniGene; Hs.7099; -.
DR   ProteinModelPortal; Q5H8A4; -.
DR   BioGrid; 120220; 8.
DR   IntAct; Q5H8A4; 1.
DR   MINT; MINT-3042035; -.
DR   STRING; 9606.ENSP00000415203; -.
DR   iPTMnet; Q5H8A4; -.
DR   PhosphoSitePlus; Q5H8A4; -.
DR   BioMuta; PIGG; -.
DR   DMDM; 74707851; -.
DR   MaxQB; Q5H8A4; -.
DR   PaxDb; Q5H8A4; -.
DR   PeptideAtlas; Q5H8A4; -.
DR   PRIDE; Q5H8A4; -.
DR   Ensembl; ENST00000310340; ENSP00000311750; ENSG00000174227. [Q5H8A4-2]
DR   Ensembl; ENST00000383028; ENSP00000372494; ENSG00000174227. [Q5H8A4-3]
DR   Ensembl; ENST00000453061; ENSP00000415203; ENSG00000174227. [Q5H8A4-1]
DR   Ensembl; ENST00000503111; ENSP00000426002; ENSG00000174227. [Q5H8A4-5]
DR   GeneID; 54872; -.
DR   KEGG; hsa:54872; -.
DR   UCSC; uc003gaj.6; human. [Q5H8A4-1]
DR   CTD; 54872; -.
DR   DisGeNET; 54872; -.
DR   GeneCards; PIGG; -.
DR   HGNC; HGNC:25985; PIGG.
DR   HPA; HPA015997; -.
DR   MIM; 616917; phenotype.
DR   MIM; 616918; gene.
DR   neXtProt; NX_Q5H8A4; -.
DR   OpenTargets; ENSG00000174227; -.
DR   PharmGKB; PA143485575; -.
DR   eggNOG; KOG2125; Eukaryota.
DR   eggNOG; COG1524; LUCA.
DR   GeneTree; ENSGT00840000129928; -.
DR   HOGENOM; HOG000171439; -.
DR   HOVERGEN; HBG075245; -.
DR   InParanoid; Q5H8A4; -.
DR   KO; K05310; -.
DR   OMA; WYYLGNT; -.
DR   OrthoDB; EOG091G04HZ; -.
DR   PhylomeDB; Q5H8A4; -.
DR   TreeFam; TF300609; -.
DR   Reactome; R-HSA-162710; Synthesis of glycosylphosphatidylinositol (GPI).
DR   UniPathway; UPA00196; -.
DR   ChiTaRS; PIGG; human.
DR   GenomeRNAi; 54872; -.
DR   PRO; PR:Q5H8A4; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000174227; -.
DR   CleanEx; HS_PIGG; -.
DR   ExpressionAtlas; Q5H8A4; baseline and differential.
DR   Genevisible; Q5H8A4; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0051267; F:CP2 mannose-ethanolamine phosphotransferase activity; IDA:MGI.
DR   GO; GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; TAS:Reactome.
DR   GO; GO:0006506; P:GPI anchor biosynthetic process; IDA:MGI.
DR   GO; GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; GPI-anchor biosynthesis;
KW   Membrane; Mental retardation; Polymorphism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    983       GPI ethanolamine phosphate transferase 2.
FT                                /FTId=PRO_0000246185.
FT   TOPO_DOM      1    431       Lumenal. {ECO:0000255}.
FT   TRANSMEM    432    452       Helical. {ECO:0000255}.
FT   TRANSMEM    471    491       Helical. {ECO:0000255}.
FT   TRANSMEM    506    526       Helical. {ECO:0000255}.
FT   TRANSMEM    552    572       Helical. {ECO:0000255}.
FT   TRANSMEM    699    719       Helical. {ECO:0000255}.
FT   TRANSMEM    721    741       Helical. {ECO:0000255}.
FT   TRANSMEM    752    772       Helical. {ECO:0000255}.
FT   TRANSMEM    789    809       Helical. {ECO:0000255}.
FT   TRANSMEM    812    832       Helical. {ECO:0000255}.
FT   TRANSMEM    879    899       Helical. {ECO:0000255}.
FT   TRANSMEM    919    939       Helical. {ECO:0000255}.
FT   TRANSMEM    955    975       Helical. {ECO:0000255}.
FT   CARBOHYD    194    194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    122       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054387.
FT   VAR_SEQ       1     89       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019827.
FT   VAR_SEQ     120    252       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019828.
FT   VAR_SEQ     372    388       DPGFEQFKMSERLHGNW -> GSHPAPAQRPTGTAQKG
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019829.
FT   VAR_SEQ     389    983       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019830.
FT   VAR_SEQ     430    463       YDIYSMMVGTVVVLEVLTLLLLSVPQALRRKAEL -> FSP
FT                                CSCSASHRHCTERLSWKSHCHLLGFLCSFIW (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_019831.
FT   VAR_SEQ     430    463       YDIYSMMVGTVVVLEVLTLLLLSVPQALRRKAEL -> FSP
FT                                CSCSASHRHCAERLSWKSHCHLLGFLCSFIW (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054388.
FT   VAR_SEQ     437    444       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_019832.
FT   VAR_SEQ     464    983       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019833.
FT   VARIANT      55     55       S -> Y (in dbSNP:rs34120878).
FT                                /FTId=VAR_057680.
FT   VARIANT     458    458       R -> H (in dbSNP:rs13115344).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027022.
FT   VARIANT     610    610       C -> R (in dbSNP:rs7666425).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027023.
FT   VARIANT     669    669       R -> C (in MRT53; found in a compound
FT                                heterozygote that also carries a
FT                                microdeletion encompassing PIGG; almost
FT                                complete loss of ethanolamine phosphate
FT                                transferase activity, as evidenced by
FT                                abnormal accumulation of the GPI
FT                                precursors H7 and H7' and absence of
FT                                mature GPI precursor H8 in patient
FT                                lymphocytes; does not affect protein
FT                                expression levels in transfected HEK293
FT                                cells; dbSNP:rs372392424).
FT                                {ECO:0000269|PubMed:26996948}.
FT                                /FTId=VAR_076775.
FT   VARIANT     699    699       V -> I (in dbSNP:rs13114026).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027024.
FT   VARIANT     731    731       V -> I (in dbSNP:rs34916638).
FT                                /FTId=VAR_060086.
FT   VARIANT     881    881       I -> T (in dbSNP:rs34623004).
FT                                /FTId=VAR_060087.
FT   VARIANT     932    932       F -> S (in dbSNP:rs1127410).
FT                                /FTId=VAR_027025.
FT   CONFLICT    624    624       D -> G (in Ref. 3; BAC11227).
FT                                {ECO:0000305}.
FT   CONFLICT    889    889       F -> L (in Ref. 3; BAC11227).
FT                                {ECO:0000305}.
SQ   SEQUENCE   983 AA;  108173 MW;  18D5DF737B000D2D CRC64;
     MRLGSGTFAT CCVAIEVLGI AVFLRGFFPA PVRSSARAEH GAEPPAPEPS AGASSNWTTL
     PPPLFSKVVI VLIDALRDDF VFGSKGVKFM PYTTYLVEKG ASHSFVAEAK PPTVTMPRIK
     ALMTGSLPGF VDVIRNLNSP ALLEDSVIRQ AKAAGKRIVF YGDETWVKLF PKHFVEYDGT
     TSFFVSDYTE VDNNVTRHLD KVLKRGDWDI LILHYLGLDH IGHISGPNSP LIGQKLSEMD
     SVLMKIHTSL QSKERETPLP NLLVLCGDHG MSETGSHGAS STEEVNTPLI LISSAFERKP
     GDIRHPKHVQ QTDVAATLAI ALGLPIPKDS VGSLLFPVVE GRPMREQLRF LHLNTVQLSK
     LLQENVPSYE KDPGFEQFKM SERLHGNWIR LYLEEKHSEV LFNLGSKVLR QYLDALKTLS
     LSLSAQVAQY DIYSMMVGTV VVLEVLTLLL LSVPQALRRK AELEVPLSSP GFSLLFYLVI
     LVLSAVHVIV CTSAESSCYF CGLSWLAAGG VMVLASALLC VIVSVLTNVL VGGNTPRKNP
     MHPSSRWSEL DLLILLGTAG HVLSLGASSF VEEEHQTWYF LVNTLCLALS QETYRNYFLG
     DDGEPPCGLC VEQGHDGATA AWQDGPGCDV LERDKGHGSP STSEVLRGRE KWMVLASPWL
     ILACCRLLRS LNQTGVQWAH RPDLGHWLTS SDHKAELSVL AALSLLVVFV LVQRGCSPVS
     KAALALGLLG VYCYRAAIGS VRFPWRPDSK DISKGIIEAR FVYVFVLGIL FTGTKDLLKS
     QVIAADFKLK TVGLWEIYSG LVLLAALLFR PHNLPVLAFS LLIQTLMTKF IWKPLRHDAA
     EITVMHYWFG QAFFYFQGNS NNIATVDISA GFVGLDTYVE IPAVLLTAFG TYAGPVLWAS
     HLVHFLSSET RSGSALSHAC FCYALICSIP VFTYIVLVTS LRYHLFIWSV FSPKLLYEGM
     HLLITAAVCV FFTAMDQTRL TQS
//
